Residency · Residency · Medical Genetics Genomics
Genetic Information Nondiscrimination Act (GINA) and Its Gaps
Introduction
The Genetic Information Nondiscrimination Act (GINA), enacted in 2008, is the primary federal legislation in the United States protecting individuals from discrimination based on genetic information in health insurance and employment. While GINA represented a landmark achievement, significant gaps in its protections remain, and understanding these limitations is essential for clinical geneticists and genetic counselors who must inform patients about the legal landscape.
GINA Overview
Title I: Health Insurance Protections
GINA prohibits health insurers from using genetic information to make enrollment, coverage, or premium decisions. It applies to group health plans, individual health insurance, and Medicare supplemental (Medigap) policies. Insurers cannot request or require genetic testing. They cannot use genetic test results of an individual or family member as a basis for coverage denial or premium adjustment. The law defines genetic information broadly to include an individual's genetic tests, family members' genetic tests, family medical history, participation in genetic research, and use of genetic services.
Title II: Employment Protections
GINA prohibits employers with 15 or more employees from using genetic information in hiring, firing, promotion, or other employment decisions. Employers cannot request, require, or purchase genetic information about employees or their family members. Exceptions include inadvertent acquisition (such as overhearing a conversation), voluntary wellness programs (with limitations), FMLA-related medical certifications, and commercially available genetic monitoring of workplace toxin effects. Enforcement is through the Equal Employment Opportunity Commission (EEOC).
What Counts as Genetic Information Under GINA
Covered information includes results of genetic tests (diagnostic, predictive, carrier, prenatal), genetic tests of family members (up to fourth-degree relatives), family medical history (which can reveal genetic predisposition), participation in genetic research, clinical trials, or genetic services, and fetal genetic information (prenatal testing, preimplantation genetic testing).
Significant Gaps in GINA
| Domain | GINA Protection | Key Gap/Limitation |
|---|---|---|
| Health insurance (group/individual) | Yes - cannot use genetic info for coverage/premium decisions | Does not apply once condition is "manifested" (ACA fills this gap) |
| Employment (≥15 employees) | Yes - cannot use in hiring, firing, promotion | Does not cover employers with <15 employees |
| Life insurance | No | Insurers may request and use genetic test results |
| Disability insurance | No | Insurers may request and use genetic test results |
| Long-term care insurance | No | Insurers may request and use genetic test results |
| Tricare/VHA/IHS | Not directly | Separate federal policies may provide protection |
| Education/housing | Not covered by GINA | Some states provide additional protections |
Life Insurance, Disability Insurance, and Long-Term Care Insurance
GINA does not apply to life insurance, disability insurance, or long-term care insurance. These insurers can legally request genetic test results and use them for underwriting decisions. This is the most significant gap and the most common source of patient concern. Some patients decline genetic testing specifically due to fear of life or disability insurance discrimination. State laws provide variable additional protections.
Military and Federal Employees
GINA applies to federal civilian employees through Title II. Military personnel are covered by Department of Defense policies that provide additional protections; genetic information is not used for deployment decisions but may be collected for identification purposes. Uniformed services members may face unique considerations regarding fitness-for-duty evaluations.
Small Employers
Title II applies only to employers with 15 or more employees. Employees of smaller businesses have no federal genetic nondiscrimination protection in employment.
Health Insurance Limitations
GINA does not apply to Tricare (military health system), Veterans Health Administration, or Indian Health Service (though separate policies may provide protections). It does not apply to self-funded ERISA plans for employers with fewer than 15 employees. Critically, GINA does not prevent insurers from using manifest disease for underwriting; once a genetic condition produces symptoms or a diagnosis, it is no longer considered genetic information under GINA but rather a health condition.
The Manifested Condition Distinction
GINA protects against discrimination based on genetic predisposition, not manifested genetic conditions. If a patient with a BRCA1 pathogenic variant has not developed cancer, GINA protects against health insurance discrimination based on the variant. If that patient develops breast cancer, the cancer diagnosis (not the genetic variant) can be used for health insurance purposes under pre-ACA rules. The Affordable Care Act (ACA) provides important complementary protections by prohibiting denial of coverage or premium increases based on pre-existing conditions.
State-Level Protections
Variation Across States
Many states have enacted genetic nondiscrimination laws that extend beyond GINA. Some states (including California, Florida, and Vermont) provide protections in life insurance and/or disability insurance. Protections vary significantly, and clinicians should be aware of their state's specific laws. Some states protect against genetic discrimination in education, housing, or mortgage lending.
Notable State Laws
California (CalGINA, SB 559) extends protections to emergency services, housing, mortgage lending, education, and other areas. Florida prohibits use of genetic information in life, disability, and long-term care insurance. Vermont provides comprehensive protections including life insurance. New York offers protections in life, disability, and long-term care insurance with limitations. Patients should be referred to state-specific resources for the most current protections.
International Comparisons
Canada's Genetic Non-Discrimination Act (2017) prohibits genetic discrimination in contracts and insurance and is broader than GINA but has faced constitutional challenges. The United Kingdom maintains a voluntary moratorium on insurers using predictive genetic test results; only Huntington disease testing can be used for life insurance policies above a threshold. In Australia, life insurers currently may use genetic test results, with regulatory reform under discussion. The European Union's GDPR provides strong genetic data privacy, though insurance discrimination protections vary by member state.
Clinical Implications
Pre-Test Counseling Obligations
Patients must be informed about GINA protections and their limitations before genetic testing. Specific risks regarding life, disability, and long-term care insurance should be discussed. Timing of genetic testing relative to insurance applications should be considered (some patients choose to secure insurance before testing). Documentation that genetic discrimination risks were discussed should be part of informed consent.
Practical Recommendations for Patients
Patients concerned about discrimination should secure life, disability, and long-term care insurance before undergoing predictive genetic testing. They should understand that GINA does not protect against discrimination based on a diagnosed condition (though ACA does for health insurance). State-specific protections should be reviewed. Patients should be aware that genetic test results are part of the medical record and may be accessible to insurers via authorized medical record releases.
Documentation and Data Protection
Genetic results in the medical record may be accessible to insurers via authorized medical record releases. Some patients request that genetic test results be maintained in separate files or with restricted access. HIPAA provides baseline privacy protections but does not prevent disclosure when the patient authorizes release of medical records.
Clinical Pearls
GINA provides robust protections in health insurance and employment but does not cover life insurance, disability insurance, or long-term care insurance, which is the most clinically relevant gap. The distinction between genetic predisposition (protected by GINA) and manifested genetic disease (not protected by GINA but covered by ACA) is critical for accurate patient counseling. State laws vary significantly in extending protections beyond GINA; clinicians should know their state's specific protections. Pre-test counseling must include an honest discussion of both protections and gaps in genetic nondiscrimination law to support truly informed consent.
References
- Green RC, Lautenbach D, McGuire AL. GINA, genetic discrimination, and genomic medicine. New England Journal of Medicine. 2015;372(5):397-399.
- Prince AER, Roche MI. Genetic information, non-discrimination, and privacy protections in genetic counseling practice. Journal of Genetic Counseling. 2014;23(6):891-902.
- Rothstein MA. Time to end the use of genetic test results in life insurance underwriting. Journal of Law and the Biosciences. 2018;5(3):700-708.
- Clayton EW, Evans BJ, Hazel JW, Rothstein MA. The law of genetic privacy: applications, implications, and limitations. Journal of Law and the Biosciences. 2019;6(1):1-36.